Antithrombin Market Size, Share & Trends Analysis Report By Application (Therapeutics, Diagnostics), By Source (Human, Recombinant Goat Milk), By Type, By Region, And Segment Forecasts, 2025 - 2033

PUBLISHED: October 27, 2025

PAGES: 100 Pages

DELIVERY TIME: 2-10 business days

ADD TO COMPARE

SELECT AN OPTION

The global antithrombin market size was estimated at USD 658.4 million in 2024 and is projected to reach USD 997.2 million by 2033, growing at a CAGR of 4.7% from 2025 to 2033. The rising prevalence of coagulation disorders such as deep vein thrombosis, pulmonary embolism, and hereditary antithrombin deficiency primarily drives the antithrombin market.

Increasing surgical procedures, trauma cases, and complications during pregnancy that elevate thrombosis risk are also contributing to higher demand for antithrombin therapy. The antithrombin industry is driven by the steady rise of thromboembolic and coagulation disorders, growing awareness of hereditary antithrombin deficiency, and the importance of early anticoagulant therapy. In the U.S, 900,000 people are affected by venous thromboembolism (VTE) each year, with individuals at particularly high risk during or just after hospitalization, cancer treatment, or pregnancy. An estimated 60,000 to 100,000 Americans die annually from VTE, while many others experience long-term complications, thus highlighting the critical need for effective prevention and management.

Increasing surgical procedures, trauma incidents, and pregnancy-related complications have further amplified the demand for antithrombin therapy. Treatment options worldwide include plasma-derived and recombinant formulations, with recombinant products gaining wider acceptance due to higher safety, purity, and reduced infection risks. The expansion of their use in critical care, cardiac surgeries, and obstetric cases, supported by advancements in biotechnology and favorable regulatory approvals, continues to propel the global antithrombin market forward.

Global Antithrombin Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global antithrombin market report based on application, source, type, and region:

Application Outlook (Revenue, USD Million, 2021 - 2033)
Therapeutics
Diagnostics
Research
Other
Source Outlook (Revenue, USD Million, 2021 - 2033)
Human
Recombinant Goat Milk
Others
Type Outlook (Revenue, USD Million, 2021 - 2033)
Anticoagulant
Antiplatelet
Thrombolytic Drugs
Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Italy
- Spain
- Sweden
- Denmark
- Norway
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- Thailand
Latin America
- Brazil
- Argentina
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait

Product Code: GVR-4-68040-781-8

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Segment Definitions
- 1.2.1. Application
- 1.2.2. Source
- 1.2.3. Type
- 1.2.4. Regional scope
- 1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
1.5. Information or Data Analysis
- 1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.8. List of Secondary Source
1.9. List of Primary Source
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
- 2.2.1. Application outlook
- 2.2.2. Source outlook
- 2.2.3. Type outlook
- 2.2.4. Regional outlook
2.3. Competitive Insights

Chapter 3. Antithrombin Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.2. Market restraint analysis
3.3. Antithrombin Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
  - 3.3.1.1. Supplier power
  - 3.3.1.2. Buyer power
  - 3.3.1.3. Substitution threat
  - 3.3.1.4. Threat of new entrant
  - 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
  - 3.3.2.1. Political landscape
  - 3.3.2.2. Technological landscape
  - 3.3.2.3. Economic landscape

Chapter 4. Antithrombin Market: Application Estimates & Trend Analysis

4.1. Application Segment Dashboard
4.2. Antithrombin Market: Application Movement Analysis
4.3. Global Antithrombin Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
- 4.3.1. Therapeutics
  - 4.3.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 4.3.2. Diagnostics
  - 4.3.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 4.3.3. Research
  - 4.3.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 4.3.4. Other
  - 4.3.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. Antithrombin Market: Source Estimates & Trend Analysis

5.1. Source Segment Dashboard
5.2. Antithrombin Market: Source Movement Analysis
5.3. Global Antithrombin Market Size & Trend Analysis, by Source, 2021 to 2033 (USD Million)
- 5.3.1. Human
  - 5.3.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 5.3.2. Recombinant Goat Milk
  - 5.3.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 5.3.3. Others
  - 5.3.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. Antithrombin Market: Type Estimates & Trend Analysis

6.1. Type Segment Dashboard
6.2. Antithrombin Market: Type Movement Analysis
6.3. Global Antithrombin Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
- 6.3.1. Anticoagulant
  - 6.3.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 6.3.2. Antiplatelet
  - 6.3.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 6.3.3. Thrombolytic Drugs
  - 6.3.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Antithrombin Market: Regional Estimates & Trend Analysis

7.1. Regional Market Dashboard
7.2. Regional Market Share Analysis, 2024 & 2030
7.3. Antithrombin Market by Region: Key Takeaways
7.4. North America
- 7.4.1. U.S.
  - 7.4.1.1. Key country dynamics
  - 7.4.1.2. Regulatory framework/ reimbursement structure
  - 7.4.1.3. Competitive scenario
  - 7.4.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
- 7.4.2. Canada
  - 7.4.2.1. Key country dynamics
  - 7.4.2.2. Regulatory framework/ reimbursement structure
  - 7.4.2.3. Competitive scenario
  - 7.4.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
- 7.4.3. Mexico
  - 7.4.3.1. Key country dynamics
  - 7.4.3.2. Regulatory framework/ reimbursement structure
  - 7.4.3.3. Competitive scenario
  - 7.4.3.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
7.5. Europe
- 7.5.1. UK
  - 7.5.1.1. Key country dynamics
  - 7.5.1.2. Regulatory framework/ reimbursement structure
  - 7.5.1.3. Competitive scenario
  - 7.5.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
- 7.5.2. Germany
  - 7.5.2.1. Key country dynamics
  - 7.5.2.2. Regulatory framework/ reimbursement structure
  - 7.5.2.3. Competitive scenario
  - 7.5.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
- 7.5.3. France
  - 7.5.3.1. Key country dynamics
  - 7.5.3.2. Regulatory framework/ reimbursement structure
  - 7.5.3.3. Competitive scenario
  - 7.5.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
- 7.5.4. Italy
  - 7.5.4.1. Key country dynamics
  - 7.5.4.2. Regulatory framework/ reimbursement structure
  - 7.5.4.3. Competitive scenario
  - 7.5.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
- 7.5.5. Spain
  - 7.5.5.1. Key country dynamics
  - 7.5.5.2. Regulatory framework/ reimbursement structure
  - 7.5.5.3. Competitive scenario
  - 7.5.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
- 7.5.6. Sweden
  - 7.5.6.1. Key country dynamics
  - 7.5.6.2. Regulatory framework/ reimbursement structure
  - 7.5.6.3. Competitive scenario
  - 7.5.6.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
- 7.5.7. Denmark
  - 7.5.7.1. Key country dynamics
  - 7.5.7.2. Regulatory framework/ reimbursement structure
  - 7.5.7.3. Competitive scenario
  - 7.5.7.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
- 7.5.8. Norway
  - 7.5.8.1. Key country dynamics
  - 7.5.8.2. Regulatory framework/ reimbursement structure
  - 7.5.8.3. Competitive scenario
  - 7.5.8.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
7.6. Asia Pacific
- 7.6.1. China
  - 7.6.1.1. Key country dynamics
  - 7.6.1.2. Regulatory framework/ reimbursement structure
  - 7.6.1.3. Competitive scenario
  - 7.6.1.4. China market estimates and forecasts 2021 to 2033 (USD Million)
- 7.6.2. India
  - 7.6.2.1. Key country dynamics
  - 7.6.2.2. Regulatory framework/ reimbursement structure
  - 7.6.2.3. Competitive scenario
  - 7.6.2.4. India market estimates and forecasts 2021 to 2033 (USD Million)
- 7.6.3. Japan
  - 7.6.3.1. Key country dynamics
  - 7.6.3.2. Regulatory framework/ reimbursement structure
  - 7.6.3.3. Competitive scenario
  - 7.6.3.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
- 7.6.4. Australia
  - 7.6.4.1. Key country dynamics
  - 7.6.4.2. Regulatory framework/ reimbursement structure
  - 7.6.4.3. Competitive scenario
  - 7.6.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
- 7.6.5. South Korea
  - 7.6.5.1. Key country dynamics
  - 7.6.5.2. Regulatory framework/ reimbursement structure
  - 7.6.5.3. Competitive scenario
  - 7.6.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
- 7.6.6. Thailand
  - 7.6.6.1. Key country dynamics
  - 7.6.6.2. Regulatory framework/ reimbursement structure
  - 7.6.6.3. Competitive scenario
  - 7.6.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
7.7. Latin America
- 7.7.1. Brazil
  - 7.7.1.1. Key country dynamics
  - 7.7.1.2. Regulatory framework/ reimbursement structure
  - 7.7.1.3. Competitive scenario
  - 7.7.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
- 7.7.2. Argentina
  - 7.7.2.1. Key country dynamics
  - 7.7.2.2. Regulatory framework/ reimbursement structure
  - 7.7.2.3. Competitive scenario
  - 7.7.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
7.8. MEA
- 7.8.1. South Africa
  - 7.8.1.1. Key country dynamics
  - 7.8.1.2. Regulatory framework/ reimbursement structure
  - 7.8.1.3. Competitive scenario
  - 7.8.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
- 7.8.2. Saudi Arabia
  - 7.8.2.1. Key country dynamics
  - 7.8.2.2. Regulatory framework/ reimbursement structure
  - 7.8.2.3. Competitive scenario
  - 7.8.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
- 7.8.3. UAE
  - 7.8.3.1. Key country dynamics
  - 7.8.3.2. Regulatory framework/ reimbursement structure
  - 7.8.3.3. Competitive scenario
  - 7.8.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
- 7.8.4. Kuwait
  - 7.8.4.1. Key country dynamics
  - 7.8.4.2. Regulatory framework/ reimbursement structure
  - 7.8.4.3. Competitive scenario
  - 7.8.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 8. Competitive Landscape

8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.3. Vendor Landscape
- 8.3.1. Key company heat map analysis, 2024
8.4. Company Profiles
- 8.4.1. CSL
  - 8.4.1.1. Company overview
  - 8.4.1.2. Financial performance
  - 8.4.1.3. Product benchmarking
  - 8.4.1.4. Strategic initiatives
- 8.4.2. Grifols, S.A.
  - 8.4.2.1. Company overview
  - 8.4.2.2. Financial performance
  - 8.4.2.3. Product benchmarking
  - 8.4.2.4. Strategic initiatives
- 8.4.3. Takeda Pharmaceutical Company Limited.
  - 8.4.3.1. Company overview
  - 8.4.3.2. Financial performance
  - 8.4.3.3. Product benchmarking
  - 8.4.3.4. Strategic initiatives
- 8.4.4. Octapharma AG
  - 8.4.4.1. Company overview
  - 8.4.4.2. Financial performance
  - 8.4.4.3. Product benchmarking
  - 8.4.4.4. Strategic initiatives
- 8.4.5. LFB
  - 8.4.5.1. Company overview
  - 8.4.5.2. Financial performance
  - 8.4.5.3. Product benchmarking
  - 8.4.5.4. Strategic initiatives
- 8.4.6. ENDPOINT HEALTH, INC.
  - 8.4.6.1. Company overview
  - 8.4.6.2. Financial performance
  - 8.4.6.3. Product benchmarking
  - 8.4.6.4. Strategic initiatives
- 8.4.7. Siemens Healthineers AG
  - 8.4.7.1. Company overview
  - 8.4.7.2. Financial performance
  - 8.4.7.3. Product benchmarking
  - 8.4.7.4. Strategic initiatives
- 8.4.8. Thermo Fisher Scientific Inc.
  - 8.4.8.1. Company overview
  - 8.4.8.2. Financial performance
  - 8.4.8.3. Product benchmarking
  - 8.4.8.4. Strategic initiatives
- 8.4.9. Medix Biochemica
  - 8.4.9.1. Company overview
  - 8.4.9.2. Financial performance
  - 8.4.9.3. Product benchmarking
  - 8.4.9.4. Strategic initiatives

Product Code: GVR-4-68040-781-8

List of Tables

Table 1 List of abbreviations
Table 2 Global antithrombin market, by region, 2021 - 2033 (USD Million)
Table 3 Global antithrombin market, by application, 2021 - 2033 (USD Million)
Table 4 Global antithrombin market, by source, 2021 - 2033 (USD Million)
Table 5 Global antithrombin market, by type, 2021 - 2033 (USD Million)
Table 6 North America antithrombin market, by country, 2021 - 2033 (USD Million)
Table 7 North America antithrombin market, by application, 2021 - 2033 (USD Million)
Table 8 North America antithrombin market, by sources, 2021 - 2033 (USD Million)
Table 9 North America antithrombin market, by type, 2021 - 2033 (USD Million)
Table 10 U.S. antithrombin market, by application, 2021 - 2033 (USD Million)
Table 11 U.S. antithrombin market, by source, 2021 - 2033 (USD Million)
Table 12 U.S. antithrombin market, by type, 2021 - 2033 (USD Million)
Table 13 Canada antithrombin market, by application, 2021 - 2033 (USD Million)
Table 14 Canada antithrombin market, by source, 2021 - 2033 (USD Million)
Table 15 Canada antithrombin market, by type, 2021 - 2033 (USD Million)
Table 16 Mexico antithrombin market, by application, 2021 - 2033 (USD Million)
Table 17 Mexico antithrombin market, by source, 2021 - 2033 (USD Million)
Table 18 Mexico antithrombin market, by type, 2021 - 2033 (USD Million)
Table 19 Europe antithrombin market, by country, 2021 - 2033 (USD Million)
Table 20 Europe antithrombin market, by application, 2021 - 2033 (USD Million)
Table 21 Europe antithrombin market, by source, 2021 - 2033 (USD Million)
Table 22 Europe antithrombin market, by type, 2021 - 2033 (USD Million)
Table 23 Germany antithrombin market, by application, 2021 - 2033 (USD Million)
Table 24 Germany antithrombin market, by source, 2021 - 2033 (USD Million)
Table 25 Germany antithrombin market, by type, 2021 - 2033 (USD Million)
Table 26 UK antithrombin market, by application, 2021 - 2033 (USD Million)
Table 27 UK antithrombin market, by source, 2021 - 2033 (USD Million)
Table 28 UK antithrombin market, by type, 2021 - 2033 (USD Million)
Table 29 France antithrombin market, by application, 2021 - 2033 (USD Million)
Table 30 France antithrombin market, by source, 2021 - 2033 (USD Million)
Table 31 France antithrombin market, by type, 2021 - 2033 (USD Million)
Table 32 Italy antithrombin market, by application, 2021 - 2033 (USD Million)
Table 33 Italy antithrombin market, by source, 2021 - 2033 (USD Million)
Table 34 Italy antithrombin market, by type, 2021 - 2033 (USD Million)
Table 35 Spain antithrombin market, by application, 2021 - 2033 (USD Million)
Table 36 Spain antithrombin market, by source, 2021 - 2033 (USD Million)
Table 37 Spain antithrombin market, by type, 2021 - 2033 (USD Million)
Table 38 Sweden antithrombin market, by application, 2021 - 2033 (USD Million)
Table 39 Sweden antithrombin market, by source, 2021 - 2033 (USD Million)
Table 40 Sweden antithrombin market, by type, 2021 - 2033 (USD Million)
Table 41 Denmark antithrombin market, by application, 2021 - 2033 (USD Million)
Table 42 Denmark antithrombin market, by source, 2021 - 2033 (USD Million)
Table 43 Denmark antithrombin market, by type, 2021 - 2033 (USD Million)
Table 44 Norway antithrombin market, by application, 2021 - 2033 (USD Million)
Table 45 Norway antithrombin market, by source, 2021 - 2033 (USD Million)
Table 46 Norway antithrombin market, by type, 2021 - 2033 (USD Million)
Table 47 Asia Pacific antithrombin market, by country, 2021 - 2033 (USD Million)
Table 48 Asia Pacific antithrombin market, by application, 2021 - 2033 (USD Million)
Table 49 Asia Pacific antithrombin market, by source, 2021 - 2033 (USD Million)
Table 50 Asia Pacific antithrombin market, by type, 2021 - 2033 (USD Million)
Table 51 China antithrombin market, by application, 2021 - 2033 (USD Million)
Table 52 China antithrombin market, by source, 2021 - 2033 (USD Million)
Table 53 China antithrombin market, by type, 2021 - 2033 (USD Million)
Table 54 India antithrombin market, by application, 2021 - 2033 (USD Million)
Table 55 India antithrombin market, by source, 2021 - 2033 (USD Million)
Table 56 India antithrombin market, by type, 2021 - 2033 (USD Million)
Table 57 Japan antithrombin market, by application, 2021 - 2033 (USD Million)
Table 58 Japan antithrombin market, by source, 2021 - 2033 (USD Million)
Table 59 Japan antithrombin market, by type, 2021 - 2033 (USD Million)
Table 60 Australia antithrombin market, by application, 2021 - 2033 (USD Million)
Table 61 Australia antithrombin market, by source, 2021 - 2033 (USD Million)
Table 62 Australia antithrombin market, by type, 2021 - 2033 (USD Million)
Table 63 South Korea antithrombin market, by application, 2021 - 2033 (USD Million)
Table 64 South Korea antithrombin market, by source, 2021 - 2033 (USD Million)
Table 65 South Korea antithrombin market, by type, 2021 - 2033 (USD Million)
Table 66 Thailand antithrombin market, by application, 2021 - 2033 (USD Million)
Table 67 Thailand antithrombin market, by source, 2021 - 2033 (USD Million)
Table 68 Thailand antithrombin market, by type, 2021 - 2033 (USD Million)
Table 69 Latin America antithrombin market, by country, 2021 - 2033 (USD Million)
Table 70 Latin America antithrombin market, by application, 2021 - 2033 (USD Million)
Table 71 Latin America antithrombin market, by source, 2021 - 2033 (USD Million)
Table 72 Latin America antithrombin market, by type, 2021 - 2033 (USD Million)
Table 73 Brazil antithrombin market, by application, 2021 - 2033 (USD Million)
Table 74 Brazil antithrombin market, by source, 2021 - 2033 (USD Million)
Table 75 Brazil antithrombin market, by type, 2021 - 2033 (USD Million)
Table 76 Argentina antithrombin market, by application, 2021 - 2033 (USD Million)
Table 77 Argentina antithrombin market, by source, 2021 - 2033 (USD Million)
Table 78 Argentina antithrombin market, by type, 2021 - 2033 (USD Million)
Table 79 Middle East & Africa antithrombin market, by country, 2021 - 2033 (USD Million)
Table 80 Middle East & Africa antithrombin market, by application, 2021 - 2033 (USD Million)
Table 81 Middle East & Africa antithrombin market, by source, 2021 - 2033 (USD Million)
Table 82 Middle East & Africa antithrombin market, by type, 2021 - 2033 (USD Million)
Table 83 South Africa antithrombin market, by application, 2021 - 2033 (USD Million)
Table 84 South Africa antithrombin market, by source, 2021 - 2033 (USD Million)
Table 85 South Africa antithrombin market, by type, 2021 - 2033 (USD Million)
Table 86 Saudi Arabia antithrombin market, by application, 2021 - 2033 (USD Million)
Table 87 Saudi Arabia antithrombin market, by source, 2021 - 2033 (USD Million)
Table 88 Saudi Arabia antithrombin market, by type, 2021 - 2033 (USD Million)
Table 89 UAE antithrombin market, by application, 2021 - 2033 (USD Million)
Table 90 UAE antithrombin market, by source, 2021 - 2033 (USD Million)
Table 91 UAE antithrombin market, by type, 2021 - 2033 (USD Million)
Table 92 Kuwait antithrombin market, by application, 2021 - 2033 (USD Million)
Table 93 Kuwait antithrombin market, by source, 2021 - 2033 (USD Million)
Table 94 Kuwait antithrombin market, by type, 2021 - 2033 (USD Million)